HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 279, Issue 32, 33063-33070, August 6, 2004

This Article Full Text Full Text (PDF) All Versions of this Article: 279/32/33063    most recent M313462200v1 Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Moon, S.-K. Articles by Kim, C.-H. Search for Related Content PubMed PubMed Citation Articles by Moon, S.-K. Articles by Kim, C.-H. Social Bookmarking                      What's this?

Disialoganglioside (GD3) Synthase Gene Expression Suppresses Vascular Smooth Muscle Cell Responses via the Inhibition of ERK1/2 Phosphorylation, Cell Cycle Progression, and Matrix Metalloproteinase-9 Expression^*

Sung-Kwon Moon, Hong-Man Kim, Young-Choon Lee¶, and Cheorl-Ho Kim||

From the National Research Laboratory for Glycobiology, Ministry of Science and Technology, and Department of Biochemistry and Molecular Biology, Dongguk University College of Oriental Medicine, Kyungju City, Kyungbuk 780-714, Korea and the ^¶Faculty of Biotechnology, Dong-A University, Busan 604-714, Korea

Sialic acid-containing glycosphingolipids (gangliosides) have been implicated in the regulation of various biological phenomena such as atherosclerosis. Recent report suggests that exogenously supplied disialoganglioside (GD3) serves a dual role in vascular smooth muscle cells (VSMC) proliferation and apoptosis. However, the role of the GD3 synthase gene in VSMC responses has not yet been elucidated. To determine whether a ganglioside is able to modulate VSMC growth, the effect of overexpression of the GD3 synthase gene on DNA synthesis was examined. The results show that the overexpression of this gene has a potent inhibitory effect on DNA synthesis and ERK phosphorylation in cultured VSMC in the presence of PDGF. The suppression of the GD3 synthase gene was correlated with the down-regulation of cyclinE/CDK2, the up-regulation of the CDK inhibitor p21 and blocking of the p27 inhibition, whereas up-regulation of p53 as the result of GD3 synthase gene expression was not observed. Consistently, blockade of GD3 function with anti-GD3 antibody reversed VSMC proliferation and cell cycle proteins. The expression of the GD3 synthase gene also led to the inhibition of TNF--induced matrix metalloproteinase-9 (MMP-9) expression in VSMC as determined by zymography and immunoblot. Furthermore, GD3 synthase gene expression strongly decreased MMP-9 promoter activity in response to TNF-. This inhibition was characterized by the down-regulation of MMP-9, which was transcriptionally regulated at NF-B and activation protein-1 (AP-1) sites in the MMP-9 promoter. Finally, the overexpression of MMP-9 in GD3 synthase transfectant cells rescued VSMC proliferation. However, MMP-2 overexpression was not affected by cell proliferation. These findings suggest that the GD3 synthase gene represents a physiological modulator of VSMC responses that may contribute to plaque instability in atherosclerosis.

Received for publication, December 9, 2003 , and in revised form, May 27, 2004.

^* This work was supported by the National Research Laboratory Program (M10203000024-02J0000-01300) from the Ministry of Science and Technology, Korea (to C.-H. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Present address: Division of Food and Biotechnology, Chungju National University, Chungbuk 380-702, Korea.

^|| To whom correspondence should be addressed: NRL-Glycobiology and Dept. of Biochemistry and Molecular Biology, Dongguk University, Sukjang-Dong 707, Kyungju City, Kyungbuk 780-714, Korea. Tel.: 82-54-770-2663; Fax: 82-54-770-2281; E-mail: chkimbio{at}dongguk.ac.kr.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				D.-I. Kim, S.-J. Lee, S.-B. Lee, K. Park, W.-J. Kim, and S.-K. Moon Requirement for Ras/Raf/ERK pathway in naringin-induced G1-cell-cycle arrest via p21WAF1 expression Carcinogenesis, September 1, 2008; 29(9): 1701 - 1709. [Abstract] [Full Text] [PDF]

				H. Li, J. Liang, D. H. Castrillon, R. A. DePinho, E. N. Olson, and Z.-P. Liu FoxO4 Regulates Tumor Necrosis Factor Alpha-Directed Smooth Muscle Cell Migration by Activating Matrix Metalloproteinase 9 Gene Transcription Mol. Cell. Biol., April 1, 2007; 27(7): 2676 - 2686. [Abstract] [Full Text] [PDF]

				Z. Wang, Z. Sun, A. V. Li, and K. J. Yarema Roles for UDP-GlcNAc 2-Epimerase/ManNAc 6-Kinase outside of Sialic Acid Biosynthesis: MODULATION OF SIALYLTRANSFERASE AND BiP EXPRESSION, GM3 AND GD3 BIOSYNTHESIS, PROLIFERATION, AND APOPTOSIS, AND ERK1/2 PHOSPHORYLATION J. Biol. Chem., September 15, 2006; 281(37): 27016 - 27028. [Abstract] [Full Text] [PDF]

				S.-K. Moon, S.-K. Kang, and C.-H. Kim Reactive oxygen species mediates disialoganglioside GD3-induced inhibition of ERK1/2 and matrix metalloproteinase-9 expression in vascular smooth muscle cells FASEB J, July 1, 2006; 20(9): 1387 - 1395. [Abstract] [Full Text] [PDF]

				B. Lee and S.-K. Moon Resveratrol Inhibits TNF-{alpha}-Induced Proliferation and Matrix Metalloproteinase Expression in Human Vascular Smooth Muscle Cells J. Nutr., December 1, 2005; 135(12): 2767 - 2773. [Abstract] [Full Text] [PDF]

				S. Hong, K.-K. Park, J. Magae, K. Ando, T.-S. Lee, T. K. Kwon, J.-Y. Kwak, C.-H. Kim, and Y.-C. Chang Ascochlorin Inhibits Matrix Metalloproteinase-9 Expression by Suppressing Activator Protein-1-mediated Gene Expression through the ERK1/2 Signaling Pathway: INHIBITORY EFFECTS OF ASCOCHLORIN ON THE INVASION OF RENAL CARCINOMA CELLS J. Biol. Chem., July 1, 2005; 280(26): 25202 - 25209. [Abstract] [Full Text] [PDF]